The Evolution of Coreceptor Tropism in HIV-infected Patients Interrupting Suppressive Antiretroviral Therapy

被引：13
|
作者：
Waters, Laura J. [1 ]
Scourfield, Andrew T. [1 ]
Marcano, Marie [1 ]
Gazzard, Brian G. [1 ]
Bower, Mark [1 ]
Nelson, Mark [1 ]
Stebbing, Justin [1 ]
机构：
[1] Chelsea & Westminster Hosp Fdn Trust, Dept Genitourinary HIV Med, London, England
来源：
CLINICAL INFECTIOUS DISEASES | 2011年 / 52卷 / 05期
关键词：
POPULATION; HAART;
D O I：
10.1093/cid/ciq198
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CCR5 antagonists may provide a well-tolerated switch option for patients experiencing tolerability or toxicity of their antiretroviral regimen. We analyzed stored samples from patients undergoing planned treatment interruptions for reasons other than virological failure, in order to analyze tropism evolution during fully suppressive antiretroviral therapy (ART). Two of 37 patients showed evidence of switching. Tropism switching after suppressive ART was uncommon in this cohort. Pretreatment human immunodeficiency virus (HIV) RNA tropism testing may help guide the switch to CCR5 antagonists in patients with undetectable HIV RNA.
引用
收藏
页码：671 / 673
页数：3
相关论文
共 50 条
  • [21] Interruption of antiretroviral therapy in chronically HIV-infected patients
    Amador, C
    Pasquau, F
    Ena, J
    Benito, C
    de Apodaca, RFR
    MEDICINA CLINICA, 2005, 125 (02): : 41 - 45
  • [22] Nephrotoxicity Associated with Antiretroviral Therapy in HIV-Infected Patients
    Rho, Mira
    Perazella, Mark A.
    CURRENT DRUG SAFETY, 2007, 2 (02) : 147 - 154
  • [23] Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy
    Soccal, Renata Mezomo
    Mainardi de Carvalho, Jose Antonio
    Bochi, Guilherme Vargas
    Moresco, Rafael Noal
    Paz da Silva, Jose Edson
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 302 - 307
  • [24] The histone deacetylase inhibitor chidamide induces intermittent viraemia in HIV-infected patients on suppressive antiretroviral therapy
    Li, J. H.
    Ma, J.
    Kang, W.
    Wang, C. F.
    Bai, F.
    Zhao, K.
    Yao, N.
    Liu, Q.
    Dang, B. L.
    Wang, B. W.
    Wei, Q. Q.
    Kang, W. Z.
    Sun, Y. T.
    HIV MEDICINE, 2020, 21 (11) : 747 - 757
  • [25] Antiretroviral therapy in HIV-infected children
    Fan, Conghai
    Zhang, Fengchao
    Chen, Chao
    MINERVA PEDIATRICA, 2019, 71 (05) : 455 - 460
  • [26] Evolution of drug interactions with antiretroviral medications in HIV-infected patients
    El Moussaoui, M.
    Lambert, I.
    Maes, N.
    Sauvage, A-S
    Frippiat, F.
    Meuris, C.
    Uurlings, F.
    Lecomte, M.
    Philippe, L.
    Fombellida, K.
    Vaira, D.
    Vercheval, C.
    Moutschen, M.
    Darcis, G.
    HIV MEDICINE, 2019, 20 : 44 - 44
  • [27] The effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Jensen-Fangel, S
    DANISH MEDICAL BULLETIN, 2004, 51 (04) : 371 - 392
  • [28] Adherence to antiretroviral therapy in HIV-infected patients in Sousse, Tunisia
    Hachfi, W.
    Bellazreg, F.
    Bougmiza, I
    Gloulou, O.
    Kaabia, N.
    Bahri, F.
    MEDECINE ET SANTE TROPICALES, 2012, 22 (01): : 105 - 107
  • [29] Costs associated with combination antiretroviral therapy in HIV-infected patients
    Yazdanpanah, Y
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) : 558 - 561
  • [30] Deprescribing of non-antiretroviral therapy in HIV-infected patients
    Blanco, Jose-Ramon
    Morillo, Ramon
    Abril, Vicente
    Escobar, Ismael
    Bernal, Enrique
    Folguera, Carlos
    Branas, Fatima
    Gimeno, Mercedes
    Ibarra, Olatz
    Iribarren, Jose-Antonio
    Lazaro, Alicia
    Marino, Ana
    Martin, Maria-Teresa
    Martinez, Esteban
    Ortega, Luis
    Olalla, Julian
    Robustillo, Aguas
    Sanchez-Conde, Matilde
    Rodriguez, Miguel-Angel
    De la Torre, Javier
    Sanchez-Rubio, Javier
    Tuset, Montse
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (03) : 305 - 318
12345